Juventas Cell Therapy Ltd.
2Patents
2Active
2Granted
51Portfolio score
Filing activity: Aug 26, 2021 → Aug 26, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11547728B2 | CD19-targeted chimeric antigen receptor and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11497771B2 | Plasmid combination and application thereof in preparing modified immune cells | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.